Opportunity Information: Apply for RFA CA 22 050
The NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional) is a National Institutes of Health (NIH) funding opportunity from the National Cancer Institute (NCI) that invites applications for R01 research project grants proposing independent cancer-relevant studies that align with NCIs scientific mission. The main purpose of this program is not only to support strong cancer research, but also to broaden who is leading that research. In practical terms, the CMSDP is designed to increase the number of Early Stage Investigators (ESIs) from underrepresented groups (URGs) who successfully receive R01 awards, while strengthening the overall research enterprise by diversifying NCIs investigator pool. The announcement explicitly points applicants to NIH guidance on diversity (for example, NOT-OD-20-031, NIHs Notice of Interest in Diversity), signaling that the program is part of a larger NIH-wide effort to improve representation across the biomedical research workforce.
This opportunity uses the R01 mechanism and is labeled "Clinical Trial Optional," meaning applicants may propose either clinical trial research or non-clinical trial research, as long as the project fits within NCIs mission and the specific expectations of the FOA. Because this is an R01, the program is aimed at supporting independent, investigator-driven projects rather than training or career development awards, and it is especially focused on helping qualified ESIs from URGs reach the milestone of securing an independent R01, which is often a key step in establishing a long-term research career and lab program.
Eligibility is broad and includes many types of U.S.-based organizations and public entities. Eligible applicants listed include state governments, county governments, city or township governments, special district governments, and independent school districts, along with public and state-controlled institutions of higher education and private institutions of higher education. The FOA also allows applications from Native American tribal governments that are federally recognized, as well as tribal organizations that are not federally recognized tribal governments. A wide range of nonprofit organizations are eligible, including those with 501(c)(3) status and those without 501(c)(3) status (in both cases, other than institutions of higher education). For-profit organizations other than small businesses, small businesses, and other organization types are also included among eligible applicants. In addition, the FOA highlights specific institution and organization categories that are encouraged or explicitly included as eligible, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). It also notes eligible agencies of the federal government, faith-based or community-based organizations, regional organizations, and U.S. territories or possessions.
The foreign eligibility rules are specific. Non-domestic (non-U.S.) entities, including foreign organizations and foreign institutions, are not eligible to apply as the applicant organization. Non-domestic components of U.S. organizations are also not eligible to apply. However, the FOA allows "foreign components" as defined in the NIH Grants Policy Statement, which generally means that while the main applicant must be eligible and domestic, certain defined parts of the project work may be conducted outside the U.S. when justified and consistent with NIH policy.
Administratively, the opportunity is identified as RFA-CA-22-050 and falls under the discretionary grant category. The funding activity category is listed under education and health, and the CFDA number associated with the program is 93.398. The posting indicates an original closing date of February 6, 2024, and a creation date of September 1, 2022. An explicit award ceiling amount and expected number of awards are not provided in the supplied source data, which typically means applicants would need to consult the full FOA text or NIH funding page for any budget limits, project period constraints, and the final details on anticipated award numbers.
Overall, the CMSDP can be understood as an NCI Cancer Moonshot-aligned effort to fund competitive, independent cancer research projects through R01 support while directly addressing persistent gaps in representation among R01-funded Early Stage Investigators. It combines a standard NIH research grant structure with a clear programmatic emphasis on expanding participation and strengthening the cancer research workforce by supporting investigators from underrepresented backgrounds and institutions that serve historically underrepresented communities.Apply for RFA CA 22 050
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.398.
- This funding opportunity was created on 2022-09-01.
- Applicants must submit their applications by 2024-02-06. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional) - RFA-CA-22-050
What is the NCI Cancer Moonshot Scholars Diversity Program (CMSDP)?
The CMSDP is a National Institutes of Health (NIH) funding opportunity from the National Cancer Institute (NCI) that invites applications for R01 research project grants proposing independent cancer-relevant studies that align with NCI's scientific mission.
What is the main purpose of this funding opportunity?
The program is designed to support strong, cancer-relevant independent research while also broadening who leads that research. Specifically, it aims to increase the number of Early Stage Investigators (ESIs) from underrepresented groups (URGs) who successfully receive R01 awards and to diversify NCI's investigator pool.
What grant mechanism does CMSDP use?
This opportunity uses the NIH R01 research project grant mechanism, which supports independent, investigator-driven research projects.
Is this opportunity focused on training or career development awards?
No. Based on the information provided, CMSDP is an R01 research grant opportunity intended to support independent research projects rather than training or career development awards.
What does "Clinical Trial Optional" mean for this R01?
"Clinical Trial Optional" means applicants may propose either clinical trial research or non-clinical trial research, as long as the proposed project fits within NCI's mission and the expectations described in the funding opportunity announcement (FOA).
Who is the program trying to support most directly?
The program places special emphasis on helping qualified Early Stage Investigators (ESIs) from underrepresented groups (URGs) reach the milestone of securing an independent R01 award, which is often a key step in establishing a long-term research career and lab program.
How does this opportunity connect to NIH-wide diversity efforts?
The announcement explicitly points applicants to NIH guidance on diversity (for example, NOT-OD-20-031, NIH's Notice of Interest in Diversity), indicating that CMSDP is part of a broader NIH-wide effort to improve representation across the biomedical research workforce.
What kinds of research projects are appropriate for this opportunity?
Projects should be cancer-relevant, propose independent research, and align with NCI's scientific mission. The opportunity supports investigator-driven studies and permits either clinical trial or non-clinical trial approaches (consistent with the FOA).
What types of applicant organizations are eligible?
Eligibility is broad and includes many U.S.-based organizations and public entities. Examples listed include state governments, county governments, city or township governments, special district governments, and independent school districts. Eligible applicants also include public and state-controlled institutions of higher education and private institutions of higher education.
Are tribal governments and tribal organizations eligible?
Yes. The FOA allows applications from Native American tribal governments that are federally recognized, as well as tribal organizations that are not federally recognized tribal governments.
Are nonprofit organizations eligible to apply?
Yes. A wide range of nonprofits are eligible, including nonprofit organizations with 501(c)(3) status and nonprofits without 501(c)(3) status (in both cases, other than institutions of higher education).
Are for-profit organizations eligible?
Yes. For-profit organizations other than small businesses, as well as small businesses, are included among eligible applicants.
Are specific institution types highlighted or encouraged?
Yes. The FOA highlights institution and organization categories that are encouraged or explicitly included as eligible, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
Are federal agencies eligible to apply?
Yes. The FOA notes eligible agencies of the federal government.
Are faith-based or community-based organizations eligible?
Yes. Faith-based or community-based organizations are included among eligible applicants.
Are regional organizations eligible?
Yes. Regional organizations are listed among eligible applicant types.
Are U.S. territories or possessions eligible?
Yes. U.S. territories or possessions are included among eligible applicants.
Can a foreign (non-U.S.) organization apply as the main applicant?
No. Non-domestic (non-U.S.) entities, including foreign organizations and foreign institutions, are not eligible to apply as the applicant organization.
Can a non-domestic component of a U.S. organization apply?
No. Non-domestic components of U.S. organizations are also not eligible to apply as the applicant organization.
Are any international activities allowed under this opportunity?
Yes, in a limited way. The FOA allows "foreign components" as defined in the NIH Grants Policy Statement. In practical terms, the main applicant must be an eligible domestic organization, but certain defined parts of the project work may be conducted outside the U.S. when justified and consistent with NIH policy.
What is the opportunity number (FOA identifier)?
The funding opportunity announcement (FOA) identifier is RFA-CA-22-050.
What agency and institute are offering this opportunity?
This is an NIH funding opportunity offered by the National Cancer Institute (NCI).
What is the CFDA number associated with this program?
The CFDA number associated with the program is 93.398.
What is the funding category and grant type?
The opportunity is listed under the discretionary grant category, and the funding activity category is listed under education and health.
What is the original closing date shown for this opportunity?
The posting indicates an original closing date of February 6, 2024.
What is the creation date of the opportunity listing?
The creation date is September 1, 2022.
Is there an award ceiling amount listed in the provided information?
No. An explicit award ceiling amount is not provided in the supplied source data.
Is the expected number of awards provided?
No. The expected number of awards is not provided in the supplied source data.
Where would applicants typically look for budget limits, project period constraints, or anticipated award numbers?
Because those details are not included in the provided information, applicants would typically need to consult the full FOA text or the NIH funding page for final details such as budget limits, project period constraints, and anticipated award numbers.
What does it mean that this is "Cancer Moonshot-aligned"?
Based on the information provided, the program is described as Cancer Moonshot-aligned in the sense that it supports competitive, independent cancer research projects through R01 funding while also directly addressing gaps in representation among R01-funded Early Stage Investigators.
What is the overall takeaway of the CMSDP opportunity?
CMSDP combines a standard NIH R01 research grant structure with a clear programmatic emphasis on expanding participation and strengthening the cancer research workforce by supporting investigators from underrepresented backgrounds and institutions that serve historically underrepresented communities.
Browse more opportunities from the same category: Education, Health
Next opportunity: Clinical, Behavioral, and Physiological Studies of Open- and Closed-loop Platforms: Toward Personalized, Fully Automated, Accessible Systems (R01 Clinical Trial Required)
Previous opportunity: Drug Induced Liver Injury Network (DILIN) Clinical Centers (U01 - Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 22 050
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 22 050) also looked into and applied for these:
| Funding Opportunity |
|---|
| Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) Apply for PAR 22 202 Funding Number: PAR 22 202 Agency: National Institutes of Health Category: Education, Health Funding Amount: $5,000,000 |
| Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) Apply for PAR 22 243 Funding Number: PAR 22 243 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) Apply for PAR 22 242 Funding Number: PAR 22 242 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R21 Clinical Trial Optional) Apply for PAR 22 231 Funding Number: PAR 22 231 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R01 Clinical Trial Optional) Apply for PAR 22 230 Funding Number: PAR 22 230 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed) Apply for RFA CA 22 055 Funding Number: RFA CA 22 055 Agency: National Institutes of Health Category: Education, Health Funding Amount: $720,000 |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) Apply for RFA CA 22 036 Funding Number: RFA CA 22 036 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed) Apply for RFA CA 22 035 Funding Number: RFA CA 22 035 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) Apply for RFA CA 22 037 Funding Number: RFA CA 22 037 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Large Scale Integrated Mapping and Molecular Profiling of Cell Ensembles and/or Cell-Types Mediating Opioid Action in the Rodent Brain (R01 - Clinical Trial Not Allowed) Apply for RFA DA 23 035 Funding Number: RFA DA 23 035 Agency: National Institutes of Health Category: Education, Health Funding Amount: $700,000 |
| HEAL Initiative: HEAL Data2Action Acceleration Projects (R33 Clinical Trial Not Allowed) Apply for RFA DA 23 058 Funding Number: RFA DA 23 058 Agency: National Institutes of Health Category: Education, Health Funding Amount: $750,000 |
| HEAL Initiative: HEAL Data2Action Innovation and Acceleration Projects, Phased Awards (R61/R33, Clinical Trial Optional) Apply for RFA DA 23 057 Funding Number: RFA DA 23 057 Agency: National Institutes of Health Category: Education, Health Funding Amount: $750,000 |
| Advancing Adolescent Tobacco Cessation Intervention Research (R34 Clinical Trial Optional) Apply for RFA CA 22 042 Funding Number: RFA CA 22 042 Agency: National Institutes of Health Category: Education, Health Funding Amount: $450,000 |
| Advancing Adolescent Tobacco Cessation Intervention Research (R01 Clinical Trial Required) Apply for RFA CA 22 043 Funding Number: RFA CA 22 043 Agency: National Institutes of Health Category: Education, Health Funding Amount: $3,150,000 |
| Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U01 Clinical Trial Not Allowed) Apply for RFA CA 22 052 Funding Number: RFA CA 22 052 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Coordinating Center for Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U24 Clinical Trial Not Allowed) Apply for RFA CA 22 053 Funding Number: RFA CA 22 053 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) Apply for RFA CA 22 051 Funding Number: RFA CA 22 051 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R01 Clinical Trial Optional) Apply for RFA DA 23 061 Funding Number: RFA DA 23 061 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R21 Clinical Trial Not Allowed) Apply for RFA CA 22 057 Funding Number: RFA CA 22 057 Agency: National Institutes of Health Category: Education, Health Funding Amount: $275,000 |
| NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34 Clinical Trial Optional) Apply for RFA DA 23 062 Funding Number: RFA DA 23 062 Agency: National Institutes of Health Category: Education, Health Funding Amount: $450,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 22 050", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.